Award
Delivery Order #SPE2DR26F9GAB
Delivery Order for Insulin Supply to AmerisourceBergen
Buyer
Defense Logistics Agency
Award Amount
$49.44
Ceiling
$49.44
Awarded
March 04, 2026
Period of Performance
Mar 04, 2026 – Mar 05, 2026
Identifier
SPE2DR26F9GAB
NAICS
424210
This delivery order contract represents a specific procurement action under a broader indefinite delivery vehicle agreement awarded to AmerisourceBergen Drug Corp, a leading pharmaceutical distribution company. The order involves the acquisition of Insulin Lispro, a vital medication for diabetes management, highlighting the contract's significance in supporting public health and medical readiness. The scope covers the prompt delivery of this pharmaceutical product to a designated location in Pennsylvania, ensuring availability of critical medication. This delivery order is a competitively managed fulfillment under the existing long-term pharmaceutical supply contract, leveraging AmerisourceBergen's extensive capabilities in drug distribution. The contract period is brief, reflecting the focused nature of this procurement within the ongoing framework. The parent indefinite delivery contract facilitates sustained, multi-year access to essential pharmaceuticals, with AmerisourceBergen serving as a key partner in government healthcare supply chains.
Description
4571033955!INSULIN LISPRO 100 UNIT/ML VL 10ML